Drugs · Brain health technique

Valacyclovir

Evidence grade: Experimental

Illustration for Valacyclovir

An oral antiviral medication (Valtrex®, the prodrug of acyclovir) used for HSV-1 and HSV-2 infections; being studied as a potential therapy to reduce viral reactivation implicated in Alzheimer’s risk.

Practice
Drugs
Principle
Treatment
Tactic
Neuroprotective & Disease-modifying Therapies
Health domains
inflammation
Evidence grade
Experimental
Strength of evidence
Low
Cost
High
Effort
Low
Time commitment
Low

How to practice Valacyclovir

Approved for antiviral use (cold sores, shingles, genital herpes) but not dementia prevention. For typical antiviral indications: 500–1000 mg orally 1–2× daily as prescribed upon outbreaks. Consider speaking to a physician about suppression (daily) therapy to prevent subclinical outbreaks that could increase dementia risk - though note this is an experimental use case.

The evidence behind Valacyclovir

Valacyclovir is an antiviral medicine that stops herpes viruses from copying themselves. It's an approved, well-established treatment for cold sores, genital herpes, and shingles. In small pilot trials, it also lowered viral activity and markers of inflammation.

Impact on brain health

Observational studies link long-term herpes virus infection to a higher risk of Alzheimer's. The idea is that keeping the virus in check could limit brain inflammation and amyloid buildup, but that is unproven. In the one completed randomized trial, people with early Alzheimer's who took valacyclovir for 18 months declined faster in memory and thinking than those on placebo, with no change in amyloid, so valacyclovir isn't a dementia treatment today.

Reviewed by BetterBrain's clinical advisors · Updated November 2026 · Our science

Pair this with other habits from the same practice.

  • Evidence grade: Context Dependent

    Anti-Amyloid Monoclonal Antibodies

    FDA-approved biologic drugs that target beta-amyloid plaques to slow Alzheimer’s progression, including lecanemab (Leqembi®), donanemab (Kisunla™).

    Medium effort

  • Evidence grade: Context Dependent

    Antihypertensives

    Medications that lower blood pressure to protect vascular and brain health, including ACE inhibitors (lisinopril, enalapril), ARBs (losartan, valsartan), calcium channel blockers…

    Low effort · High cost

  • Evidence grade: Context Dependent

    GLP-1 Receptor Agonists

    A class of injectable or oral medications that mimic the hormone glucagon-like peptide-1 (GLP-1) to improve insulin sensitivity, suppress appetite, and reduce inflammation.

See all 20 drugs techniques →

Take control of your brain health

BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.

How BetterBrain worksSee pricing